These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32960931)

  • 1. The glucosyltransferase activity of C. difficile Toxin B is required for disease pathogenesis.
    Bilverstone TW; Garland M; Cave RJ; Kelly ML; Tholen M; Bouley DM; Kaye P; Minton NP; Bogyo M; Kuehne SA; Melnyk RA
    PLoS Pathog; 2020 Sep; 16(9):e1008852. PubMed ID: 32960931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucosyltransferase-dependent and independent effects of Clostridioides difficile toxins during infection.
    Peritore-Galve FC; Shupe JA; Cave RJ; Childress KO; Washington MK; Kuehne SA; Lacy DB
    PLoS Pathog; 2022 Feb; 18(2):e1010323. PubMed ID: 35176123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine Intrarectal Instillation of Purified Recombinant
    Markham NO; Bloch SC; Shupe JA; Laubacher EN; Thomas AK; Kroh HK; Childress KO; Peritore-Galve FC; Washington MK; Coffey RJ; Lacy DB
    Infect Immun; 2021 Mar; 89(4):. PubMed ID: 33468584
    [No Abstract]   [Full Text] [Related]  

  • 4. Clostridium difficile Toxin B causes epithelial cell necrosis through an autoprocessing-independent mechanism.
    Chumbler NM; Farrow MA; Lapierre LA; Franklin JL; Haslam DB; Goldenring JR; Lacy DB
    PLoS Pathog; 2012; 8(12):e1003072. PubMed ID: 23236283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrarectal instillation of Clostridium difficile toxin A triggers colonic inflammation and tissue damage: development of a novel and efficient mouse model of Clostridium difficile toxin exposure.
    Hirota SA; Iablokov V; Tulk SE; Schenck LP; Becker H; Nguyen J; Al Bashir S; Dingle TC; Laing A; Liu J; Li Y; Bolstad J; Mulvey GL; Armstrong GD; MacNaughton WK; Muruve DA; MacDonald JA; Beck PL
    Infect Immun; 2012 Dec; 80(12):4474-84. PubMed ID: 23045481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional defects in
    Gupta P; Zhang Z; Sugiman-Marangos SN; Tam J; Raman S; Julien JP; Kroh HK; Lacy DB; Murgolo N; Bekkari K; Therien AG; Hernandez LD; Melnyk RA
    J Biol Chem; 2017 Oct; 292(42):17290-17301. PubMed ID: 28842504
    [No Abstract]   [Full Text] [Related]  

  • 7. Analysis of TcdB Proteins within the Hypervirulent Clade 2 Reveals an Impact of RhoA Glucosylation on Clostridium difficile Proinflammatory Activities.
    Quesada-Gómez C; López-Ureña D; Chumbler N; Kroh HK; Castro-Peña C; Rodríguez C; Orozco-Aguilar J; González-Camacho S; Rucavado A; Guzmán-Verri C; Lawley TD; Lacy DB; Chaves-Olarte E
    Infect Immun; 2016 Jan; 84(3):856-65. PubMed ID: 26755157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxicity of Clostridium difficile toxin B does not require cysteine protease-mediated autocleavage and release of the glucosyltransferase domain into the host cell cytosol.
    Li S; Shi L; Yang Z; Feng H
    Pathog Dis; 2013 Feb; 67(1):11-8. PubMed ID: 23620115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections.
    Carter GP; Chakravorty A; Pham Nguyen TA; Mileto S; Schreiber F; Li L; Howarth P; Clare S; Cunningham B; Sambol SP; Cheknis A; Figueroa I; Johnson S; Gerding D; Rood JI; Dougan G; Lawley TD; Lyras D
    mBio; 2015 Jun; 6(3):e00551. PubMed ID: 26037121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of purified Clostridium difficile glucosylating toxins in disease pathogenesis utilizing a murine cecum injection model.
    Zhang Y; Yang Z; Gao S; Hamza T; Yfantis HG; Lipsky M; Feng H
    Anaerobe; 2017 Dec; 48():249-256. PubMed ID: 29031928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isofagomine Inhibits Multiple TcdB Variants and Protects Mice from
    Paparella AS; Brew I; Hong HA; Ferriera W; Cutting S; Lamiable-Oulaidi F; Popadynec M; Tyler PC; Schramm VL
    ACS Infect Dis; 2024 Mar; 10(3):928-937. PubMed ID: 38334357
    [No Abstract]   [Full Text] [Related]  

  • 12. Structural determinants of Clostridium difficile toxin A glucosyltransferase activity.
    Pruitt RN; Chumbler NM; Rutherford SA; Farrow MA; Friedman DB; Spiller B; Lacy DB
    J Biol Chem; 2012 Mar; 287(11):8013-20. PubMed ID: 22267739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A chimeric toxin vaccine protects against primary and recurrent Clostridium difficile infection.
    Wang H; Sun X; Zhang Y; Li S; Chen K; Shi L; Nie W; Kumar R; Tzipori S; Wang J; Savidge T; Feng H
    Infect Immun; 2012 Aug; 80(8):2678-88. PubMed ID: 22615245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an Effective Nontoxigenic Clostridioides difficile-Based Oral Vaccine against C. difficile Infection.
    Wang S; Zhu D; Sun X
    Microbiol Spectr; 2022 Jun; 10(3):e0026322. PubMed ID: 35583336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxin B is essential for virulence of Clostridium difficile.
    Lyras D; O'Connor JR; Howarth PM; Sambol SP; Carter GP; Phumoonna T; Poon R; Adams V; Vedantam G; Johnson S; Gerding DN; Rood JI
    Nature; 2009 Apr; 458(7242):1176-9. PubMed ID: 19252482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autocatalytic processing of Clostridium difficile toxin B. Binding of inositol hexakisphosphate.
    Egerer M; Giesemann T; Herrmann C; Aktories K
    J Biol Chem; 2009 Feb; 284(6):3389-95. PubMed ID: 19047051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TcdB of
    Stieglitz F; Gerhard R; Hönig R; Giehl K; Pich A
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the role of toxin B in the virulence of Clostridioides difficile based on integrated bioinformatics analyses.
    Gao Y; Gao W; Cheng J; Ma L; Su J
    Int Microbiol; 2020 Nov; 23(4):575-587. PubMed ID: 32388701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Importance of Therapeutically Targeting the Binary Toxin from
    Abeyawardhane DL; Godoy-Ruiz R; Adipietro KA; Varney KM; Rustandi RR; Pozharski E; Weber DJ
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucosyltransferase activity of Clostridium difficile Toxin B is essential for disease pathogenesis.
    Yang Z; Zhang Y; Huang T; Feng H
    Gut Microbes; 2015 Jul; 6(4):221-4. PubMed ID: 26091306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.